Nanalysis Scientific Corp. reports developments tied to portable Nuclear Magnetic Resonance spectrometers, MRI and imaging technology, and related services for industrial and research applications. Company updates describe instruments used in pharmaceutical, biotech, energy, food, materials, security, academic, and government settings, as well as a services division that maintains Nanalysis products and third-party imaging equipment.
Recurring news themes include quarterly and annual results, conference-call announcements, supply-chain and market-diversification updates, non-dilutive funding, private placement financings, equity incentive grants, and board composition changes. The company also references its long-term Canadian Air Transport Security Authority relationship for security-scanner maintenance at Canadian airports.
Nanalysis Scientific Corp. (OTCQX:NSCIF) will present at the 10th Annual Gateway Conference on September 9, 2021. CEO Sean Krakiwsky will provide insights at 11 a.m. Mountain Time, with one-on-one meetings to follow. The presentation will be webcast live. Nanalysis will also participate in the LD Micro Conference on October 12, 2021, at 9:30 a.m. MT, available both in-person and virtually. Company operates in nuclear magnetic resonance technologies and has established a strong market presence in various industries including pharmaceuticals and biotechnology.